1800011I; manufacturing and characterization services for vaccines and other biologics for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93018F00001
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $70,108
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017089 Solicitation number
- Manufacturing and Characterization Services for Vaccines and Other Biologics for Infectious Diseases Award Notice · Posted Jan 27, 2017
- Contract value 100% obligated
- $70,108.14 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$18,882 | |
| Original award | $88,990 |
About this award
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The contract does not have a set-aside designation. The services provided under this contract include development, manufacturing, and characterization of various biological materials for infectious disease research and pandemic preparedness, such as influenza virus human challenge material, Staphylococcus aureus protein A, toxoid fusion proteins, COVID-19 master cell banks, and vaccine candidates for influenza virus and SARS-CoV-2.
Quick answers
Who was awarded contract 75N93018F00001?
75N93018F00001 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 15, 2018.
How much is contract 75N93018F00001 worth?
The government has obligated $70,108 on 75N93018F00001.
Is contract 75N93018F00001 an order under another contract?
Yes. 75N93018F00001 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93018F00001 competed?
The extent of competition for 75N93018F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award